Stryker goes to extremities with $162m Memometal buy
This article was originally published in Clinica
Executive Summary
Orthopaedic big player Stryker is strengthening its presence in the extremities market by agreeing to purchase French firm Memometal Technologies for up to $162m. The deal, which is expected to close in the third quarter, is worth an initial $150m in cash plus $12m in milestone payments.